Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment
Peter M. Rosenberg, Hanna Urwitz, Anders Johannesson et al. · Journal of Hepatology · 2007
Cited by 231 works. doi:10.1016/j.jhep.2007.01.024
Authors
References
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
- Liver Biopsy
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
- Global epidemiology of hepatitis C virus infection
- Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
- Drug-Induced Hepatotoxicity
- Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
- Disease concomitance in psoriasis
- Serum markers detect the presence of liver fibrosis: A cohort study